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Thyroid eye disease (TED) requires a complex management regimen that includes regular assessment of disease severity and activity, these being the markers for treatment decisions. Mild TED is characterized by mild lid retraction and soft tissue involvement, proptosis up to 3 mm above normal, transient or no diplopia, and corneal exposure responsive to lubricants. 1 Moderate to severe TED involves more significant lid retraction (>2 mm), soft tissue involvement, proptosis more than 3 mm above normal limits, and constant or inconstant diplopia, having a substantial impact on daily activities. 1 Approximately 10% of patients develop the severest forms of TED that are sight-threatening and require immediate intervention. 2 Orbital decompression surgery is one of a number of possible interventions for TED but is a major surgery involving the removal of fat, bone, or a combination of both from the orbits. Thus, it is only offered to patients with moderate to marked proptosis with inactive disease or active and sight-threatening TED. 2, 3 Thyroid eye disease has been found to have a significant impact on quality of life related to both appearance and vision before rehabilitative surgery, 4e6 but less is known about quality of life after the rehabilitative surgeries offered to patients with TED. Evidence to date suggests there is variability in quality of life after orbital decompression, 3,7e10 but the limited quality of prior studies, some with inadequate sample size, means that there is limited reliable evidence for the psychosocial benefits of this major surgery for TED. 11 Reconstructive surgery is commonly founded on the belief that an improvement in the appearance of a disfiguring condition will lead to improved quality of life. 12 Many patients are pleased with the outcome of aesthetic enhancing procedures, but some report dissatisfaction. 13, 14 Recent studies have suggested that reduced levels of psychologic distress will only follow if surgery reduces subjective noticeability of a condition, regardless of an objectively successful result. 15 With increasing evidence that questions the relationship between clinical factors and quality of life, 16 there is a greater focus on examining the individual psychologic factors that might predict patients' psychologic adjustment to the changes in vision and appearance caused by TED. 17 Other than quality of life, there is a wealth of psychosocial factors that have not been assessed after surgery for TED, and these factors could explain some of the variance between participants that is unexplained by clinical factors. Potentially relevant factors include appearance concerns, fear of the negative evaluation of others, social comparisons, and subjective visibility, which have been found to significantly explain variability in quality of life after realignment surgery for strabismus. 18 Identifying factors that predict psychologic outcomes after reconstructive and aesthetic surgery has become a priority in recent years. 14 In the context of TED, this would enable practitioners to target specific psychologic processes when developing interventions to improve quality of life. Few studies have examined how potential psychosocial factors could explain quality of life after surgery in patients with TED. 11 Given that decompression is major surgery and patients can have unrealistic expectations that it will return them to their "normal" premorbid state, 19 an investigation of this nature is long overdue.
This study was designed to establish whether orbital decompression in patients with TED has an impact on quality of life and other psychosocial factors, the extent to which quality of life outcomes can be predicted using clinical and psychosocial measures at the time of presentation, and whether postoperative changes in the clinical and psychosocial factors could explain changes in quality of life.
Methods

Ethics
Ethical approval was obtained from the North London Research Ethics Committee (reference 11/H0724/6). Decompression of up to 3 orbital walls is part of the usual treatment at Moorfields Eye Hospital, and the study adhered to the tenets of the Declaration of Helsinki. Informed consent was obtained from all participants.
Study Design
This study used a within-subjects repeated-measures design, whereby patients were assessed before surgery and again 6 weeks and 6 months postsurgery.
Participants
Participants were recruited from Moorfields Eye Hospital, London. Patients aged 18 years or older who had received a consultant-led diagnosis of TED were approached by a researcher (SW) on the day they were listed for orbital decompression surgery and invited to take part in the study. Patients were excluded from the study if they did not have a comprehensive understanding of English (as identified by the consultant) or their consultant considered them too ill or distressed to take part in the study.
Measures
Participants were asked to provide demographic details before orbital decompression. They also completed a range of psychosocial questionnaires before and 6 weeks and 6 months after surgery. Treating clinicians provided clinical measurements at these same time points, which reflect standard follow-up times after orbital decompression surgery at Moorfields Eye Hospital.
Demographic and Clinical Measures
Self-reported age, gender, and ethnic background were collected before surgery. Participants were given a list of 11 categories that classify the various ethnic groups or backgrounds (Office for National Statistics, 2003) and asked to tick the box that best described their background. Clinical measures were collected by a clinician at each of the 3 study time points and included the length of time TED had been present (disease duration), stability of thyroid function, treatment history, laterality of TED and planned surgery, smoking status, upper and lower margin reflex distances 1 and 2 (millimeters), and the presence of superficial punctate keratitis (SPK), diplopia, or congestive orbital disease. Congestive orbital disease is associated with increased intraocular pressure, deep orbital vascular congestion, and optic neuropathy and is sometimes termed "hydraulic orbit." 20 Disease activity was measured using the widely used Clinical Activity Scale (CAS), 21 a 10-item measure of pain, redness, swelling, and impaired orbital function. Snellen visual acuity was measured for each eye 22 and converted to logarithm of the minimum angle of resolution; logarithm of the minimum angle of resolution values range between À0.20 and 2.1. A score of 2.2 was assigned to patients with countingfingers vision or worse. Optic neuropathy was considered present with abnormal Ishihara color testing (if not color-blind), and testing for a relative afferent pupillary defect was used in addition. Proptosis (millimeters) was assessed with an exophthalmometer (Oculus Q4 ), and the degree of asymmetry between eyes was noted. The need for further surgery after orbital decompression was recorded at each follow-up.
Primary Outcome Measure
The Graves' Ophthalmopathy Quality of Life (GO-QOL) questionnaire is a validated disease-specific measure 8 that has been recommended for investigation of treatments for TED. 23 The GO-QOL consists of 2 subscales: vision-related quality of life and appearance-related quality of life. 8 The Australian version of the GO-QOL 4 has been used in this study, because an item about "bicycling" has been replaced by 2 more culturally relevant items about "limitations in work" and "domestic duties." Subscale scores were calculated following questionnaire 
Psychosocial Measures
Participants were asked to complete a range of questionnaires at each time point. These were selected from a framework of adjustment to TED developed by the research team Q5 (Fig 1) , adapted from The Appearance Research Collaboration's 24 framework of adjustment to living with a disfigurement. The original version of the framework contains the constructs that have been demonstrated to be involved in psychologic adjustment to appearance-altering conditions in a body of research on the psychology of appearance. Appearing first in the framework are the predisposing factors, or social context, in which adjustment takes place, including demographic characteristics and clinical factors, such as disease severity. Next are the intervening cognitions, or thought processes, that have been identified as potentially useful in explaining the difference in adjustment from patient to patient. These have been grouped into the following: social cognitions, which include fearing others' negative evaluations, making comparisons with others in a social context and perceptions of social support; appearance-specific cognitions, including appearancerelated distress, perceptions of own appearance (valence of appearance), the importance of appearance (salience of appearance), and perceived visibility of the disfigurement; and mood, which includes anxiety and depression. Psychologic well-being, or quality of life, features in the framework as the outcome of adjustment to living with a disfiguring condition. The choice of questionnaires for this study was based on the concepts from the framework identified as important predictors of quality of life in TED in a previous study. 17 Existing validated measures and brief versions of questionnaires were used where possible and are described as follows:
The Brief Fear of Negative Evaluation scale 25 measures the extent to which an individual is concerned by others' opinions of them. This validated tool consists of 12 items, and higher scores indicate a greater fear of negative evaluation from others.
The Iowa-Netherlands Comparison Orientation Measure 26 measures how well respondents feel they are doing in life when comparing himself or herself to others. Higher scores on this validated 11-item tool indicate a greater tendency to make social comparisons.
The Multidimensional Scale of Perceived Social Support 27 measures subjective levels of social support from family, friends, and significant others. Higher scores on each 4-item subscale indicate greater perceived social support.
The Derriford Appearance Scale 24 28 measures the impact of appearance-related distress on social anxiety and avoidance. Higher scores on this validated brief questionnaire represent greater levels of appearance-related distress and social avoidance.
The Centre for Appearance Research Valence Scale and Centre for Appearance Research Salience Scale 29 measure how an individual evaluates his or her own physical appearance (Centre for Appearance Research Valence Scale) and the extent to which physical appearance is important to the individual (Centre for Appearance Research Salience Scale). Higher scores on each brief measure indicate a more negative self-evaluation of appearance and that greater value is placed on appearance, respectively.
Perceived Visibility of Graves' ophthalmology (GO
Q6
): Patients were asked to rate how visible they thought their proptosis was to other people on a 7-point Likert scale from 1 (not at all visible) to 7 (extremely visible).
The Hospital Anxiety and Depression Scale 30 is designed to screen for depression and anxiety in patients with health problems. Higher total subscale scores on this validated measure indicate greater levels of anxious or depressed mood. Cutoff scores were also applied to identify noncases (0e7), doubtful cases (8e10), and cases of possible clinical anxiety or depression (scores of !11).
Statistical Analyses
An estimate of sample size was based on the required size for multilevel modeling, which assumes a hierarchical structure, whereby data are organized to reflect that time is nested within the 241  242  243  244  245  246  247  248  249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265  266  267  268  269  270  271  272  273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300   301  302  303  304  305  306  307  308  309  310  311  312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330  331  332  333  334  335  336  337  338  339  340  341  342  343  344  345  346  347  348  349  350  351  352  353  354  355  356  357  358  359  360 participant. Recent recommendations suggest that 20 to 60 participants should be recruited for each level in the structure. 31, 32 Because this study used 2 levels (time and participant), a minimum sample of 40 and a maximum of 120 were required. Multilevel modeling examined the significance of changes over time, from before to after surgery. To examine whether significant change was seen between each time point, pairwise comparisons were performed on adjusted mean scores. Effect sizes were calculated using partial eta-squared (s 2 p) when data were continuous, and the odds ratios (Expb) were calculated when data were categoric. The clinical variables optic neuropathy, SPK, diplopia, and congested orbit were the only variables assessed categorically.
Hierarchical multiple regressions were used to assess (1) whether any factors measured at baseline could predict the direction of change in quality of life (from before to after surgery) and (2) whether any factors measured before and after surgery that were found to alter with the surgery could predict the change in quality of life. Residualized change scores were calculated by regressing the variable at time 1 (baseline score) from the same variable at time 3 (6-month postoperative score). Variables entered into each regression model were chosen on the basis of their significance in predicting each dependent variable (the GO-QOL subscales) in prior univariate regression analyses (P < 0.05); the order used to enter the predictors into the regression was based on the framework outlined in Figure 1 . Entry methods were used for the hierarchical regressions, and Cohen'sf 2 was used to calculate effect sizes of each of these regressions.
As a means of a sensitivity analysis, patients who had completed only the baseline questionnaire were compared with those who completed both this and at least 1 follow-up questionnaire, using t tests and Pearson's chi-square tests (significance set to 0.05).
Results
Participants
A total of 192 patients were identified as eligible for the research. Of these, 135 (70%) agreed to take part, and 123 of the 135 (91%) returned their initial questionnaire. Two participants were removed from the baseline analysis because of high proportions of missing data (>50%). Because of small numbers of patients in some categories of ethnic background, this was collapsed into 3 groups: white ethnic background, Asian ethnic background, and black ethnic background. Of the 121 participants assessed before surgery and described in a previous publication, 17 84 (69%) responded to the 6-week follow-up questionnaire after their surgery and 86 (71%) responded to the 6-month follow-up questionnaire. Analysis of differences between responders and nonresponders found that patients of white ethnic background were more likely to respond to follow-up than other ethnic groups (chi-square [1] ¼4.79, P < 0.05), as were nonsmokers (chi-square [3] ¼11.43, P < 0.05). Baseline characteristics of the study sample are shown in Table 1 .
Postoperative Changes
All clinical variables changed significantly after surgery, as shown in Tables 2 (continuous variables) and 3 (categoric variables): For continuous variables (proptosis, asymmetry, visual acuity, lid retraction, and activity), most improvement occurred by 6 weeks after surgery, with no further statistically significant changes between 6 weeks and 6 months. This effect was also observed for the categoric variables optic neuropathy and congestive orbital disease. However, for the presence of SPK and diplopia, statistically significant improvements were not observed until 6 months after surgery.
Statistically significant improvements were also observed in the majority of psychosocial variables, with the exception of social support and social comparison ( Table 4 ). Improvements in appearance-related quality of life, mood, appearance-related social anxiety and avoidance, valence and salience of appearance, and perceived visibility were found 6 weeks after surgery and were maintained 6 months later. Changes in appearance-related quality of life reached a large minimal clinically important difference, but vision-related quality of life failed to improve statistically until 6 months after surgery, as did fear of negative evaluation (Table 4) . Appearance-related quality of life remained lower than visionrelated quality of life (Fig 2) , and a large variation between participants was observed ( Table 4 ). Because the majority of change was found at the 6-month follow-up, residualized change scores were calculated for the change from baseline to 6-month scores after surgery for each of the dependent variables described in the following sections.
Predictors of Change in Quality of Life Measured at Baseline
Vision-Related Quality of Life. Univariate linear regressions indicated that the only statistically significant preoperative predictors of change in GO-QOL visual function included ethnic background (F (1, 83) ¼5.11, P < 0.05, f 2 ¼0.06), congested orbits (F (1, 81) ¼6.24, P < 0.05, f 2 ¼0.08), diplopia (F (1, 82) ¼4.74, P < 0.05, f 2 ¼0.06), and CAS (F (1, 83) ¼11.13, P < 0.05, f 2 ¼0.10). Because these variables feature in the "predisposing factors" category in Figure 1 . Beta coefficients indicated that although the overall model was significant, there was no single significant predictor measured at baseline of change in vision-related quality of life after surgery ( Table 5 , available at wwwaaojournal.org).
Appearance-Related Quality of Life. The only statistically significant predictors of change in GO-QOL appearance measured before surgery included ethnic background (F (1, 83) ¼4.75, P < 0.05, f 2 ¼0.06), previous radiotherapy (F (1, 74) ¼4.19, P < 0.05, f 2 ¼0.06), congested orbit (F (1, 81) ¼4.72, P < 0.05, f 2 ¼0.06), diplopia (F (1, 82) ¼8.46, P < 0.05, f 2 ¼0.10), and CAS (F (1, 83) ¼7.88, P < 0.05, f 2 ¼0.09). As previously, variables were entered into the regression in 2 steps. This regression model accounted for 20% of the observed sample variation in the change in GO-QOL appearance (R 2 ¼ 0.20, F (4,70) ¼3.17, P < 0.05, f 2 ¼0.25). Beta 481  482  483  484  485  486  487  488  489  490  491  492  493  494  495  496  497  498  499  500  501  502  503  504  505  506  507  508  509  510  511  512  513  514  515  516  517  518  519  520  521  522  523  524  525  526  527  528  529  530  531  532  533  534  535  536  537  538  539  540 coefficients indicated that although the overall model was significant, there was no single predictor measured at baseline of change in appearance-related quality of life at 6 months after surgery ( Appearance-Related Quality of Life. Ten variables independently predicted change in GO-QOL appearance to a significant degree: change in upper eyelid retraction (F (1, 69) ¼4.54, P < 0.05, f 2 ¼0.07), change in congested orbit (F (1, 73) ¼4.94, P < 0.05, f 2 ¼0.07), change in support from significant others (F (1, 81) ¼7.22, P < 0.05, f 2 ¼0.09), change in family support (F (1, 82) ¼5.72, P < 0.05, f 2 ¼0.07), change in fear of negative evaluation (F (1, 71) ¼9.88, P < 0.05, f 2 ¼0.14), change in valence of appearance (F (1, 39) ¼51.86, P < 0.001, f 2 ¼1.3), change in social anxiety and social avoidance (F (1, 28) ¼19.67, P < 0.001, f 2 ¼0.70), change in perceived visibility (F (1, 75) ¼17.08, P < 0.001, f 2 ¼0.23), change in anxious mood (F (1,82) ¼11.71, P ¼ 0.001, f 2 ¼0. 14) , and change in depressed mood (F (1, 79) ¼29.57, P < 0.001, f 2 ¼0.37). When these variables were entered into the model, they accounted for 79% of the variation in GO-QOL appearance change from baseline to 6 months (R 2 ¼ 0.79, F (11, 13) ¼4.55, P < 0.05, f 2 ¼3.76). Improvement in subjective evaluation of appearance was the only variable to provide a unique contribution to predicting improvement in appearance-related quality of life from before to 6 months after surgery ( Table 8 , available at www.aaojournal.org).
Discussion
This study was designed to establish what impact orbital decompression surgery might have on clinical and psychosocial well-being, whether before surgery we can predict how well patients adjust, and whether changes in clinical and psychosocial factors from before surgery to 6 months afterward can explain changes in quality of life. Despite the resolution of optic neuropathy as early as 6 weeks after surgery, vision-related quality of life did not significantly change until 6 months after surgery and did not reach a minimal clinically important difference. It is possible that presence of double vision until 6 months after surgery might explain a continued lack of ability to carry out daily activities, including reading and driving. Double vision at baseline did contribute to the model that aimed to explain change in vision-related quality of life after surgery. Conversely, appearance-related quality of life improved significantly at 6 weeks and continued to significantly improve up to 6 months after surgery, reaching a large minimal clinically important difference. In this sample, it seems that orbital decompression has the biggest impact on appearance-related quality of life and is less effective at improving vision-related outcomes. Significant improvements in appearance-related quality of life have been observed after orbital decompression surgery in previous studies, 8, 10 although vision-related quality of life was found to show more improvement in previous studies. 3, 9, 10 However, our sample was somewhat different before surgery because less patients were affected by their vision. This is supported by the small percentage of the sample experiencing optic neuropathy before surgery.
Orbital decompression surgery attempts to improve clinical factors in TED that cause pain, discomfort, and an altered appearance. Proptosis, eyelid retraction, optic neuropathy, visual acuity, and congestive orbital disease were all found to improve as early as 6 weeks after surgery in this study, supporting the effectiveness of orbital decompression at improving these clinical outcomes. Some other variables seem to take longer to demonstrate improvement, including superficial keratitis and double vision.
Appearance-related social anxiety and avoidance, importance of appearance, personal evaluation of appearance, perceived visibility of TED, and mood were all found to improve as early as 6 weeks after surgery. Fear of negative evaluation was found not to improve until 6 months after surgery, suggesting that the emotions associated with social factors take some time to change after surgery. This finding supports previous research that has found patients often need considerable time to adjust to changes in facial appearance and might still be unsure about the reactions of others after orthognathic surgery. 33 Perceptions of social support from friends, family, and significant others remained the same over time. The tendency to make social comparisons was also found not to change after surgery, suggesting that this is a more stable characteristic.
Ethnic background was the sole demographic variable predicting change in quality of life with surgery: Patients who identified themselves as being from a nonwhite ethnic group experienced greater improvements in both vision-and appearance-related quality of life, compared with patients who identified themselves as from a white ethnic group. Individuals from nonwhite ethnic backgrounds have been found to report more worry about their appearance and an increase in perceived noticeability when they have a visible difference, 16 suggesting that this greater improvement after surgery might be due to a worse perception of their appearance before treatment. Ethnic background and a number of preoperative clinical variables were found to predict a small proportion of the variation in quality of life changes with surgery. None of these variables provided a unique contribution to the model, however, and a large proportion of the variance remains unexplained. Therefore, surgeons should be cautious about assuming that patients with particular disease severity or attitude toward their own appearance will adjust poorly after surgery. It is possible that factors not measured in this study might better explain change in some areas of quality of life, and links have been made in recent years between unmet expectations and poor psychosocial adjustment after surgery. 14 Improvements in eyelid retraction and congested orbit did not predict change in appearance-related quality of life when entered into the model with intervening cognitive process variables. These findings reflect previous surgical studies in TED that have found weak correlations between clinical changes and quality of life outcomes. 8, 34 The notion that subjective appraisals of appearance will predict psychologic well-being better than clinical measures of severity 15 also has been supported. In patients with strabismus, personal evaluation of appearance has been found to be a more important factor in predicting adjustment than other clinical factors. 18 This finding has highlighted an important intervening psychosocial factor to consider when developing future psychosocial interventions to help improve outcomes of surgery for patients with TED.
Study Limitations Q7
There are limitations to the present study. Orbital decompression is part of a treatment pathway, with some patients undergoing further surgery (e.g., eyelid lowering), and the 6-month follow-up did not assess the longer-term benefits of decompression or whether quality of life continued to improve after such further surgery. Establishing the longterm benefits of decompression and additional surgery would aid clinicians when informing patients about how much they might benefit from these various surgeries to improve their appearance and, ultimately, their quality of life. It would also be beneficial to establish whether not meeting patients' expectations of orbital decompression could influence their quality of life outcomes after surgery, as suggested in the context of aesthetic surgery. 13 841  842  843  844  845  846  847  848  849  850  851  852  853  854  855  856  857  858  859  860  861  862  863  864  865  866  867  868  869  870  871  872  873  874  875  876  877  878  879  880  881  882  883  884  885  886  887  888  889  890  891  892  893  894  895  896  897  898  899 
